Medpace Holdings Inc. (MEDP)
Why Medpace (MEDP) Outpaced the Stock Market Today
In the closing of the recent trading day, Medpace (MEDP) stood at $466.8, denoting a +1.32% move from the preceding trading day.
Why the Market Dipped But Medpace (MEDP) Gained Today
In the closing of the recent trading day, Medpace (MEDP) stood at $460.92, denoting a +1.35% move from the preceding trading day.
Aquatic Capital Management LLC Purchases 17,146 Shares of Medpace Holdings, Inc. $MEDP
Aquatic Capital Management LLC grew its position in Medpace Holdings, Inc. (NASDAQ: MEDP) by 244.5% in the undefined quarter, according to its most recent filing with the SEC. The firm owned 24,158 shares of the company's stock after buying an additional 17,146 shares during the period. Aquatic Capital Management LLC owned 0.09% of
Medpace Holdings, Inc. $MEDP Shares Purchased by Algert Global LLC
Algert Global LLC boosted its position in Medpace Holdings, Inc. (NASDAQ: MEDP) by 6.2% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 41,809 shares of the company's stock after buying an additional 2,429 shares during the period.
Medpace Holdings, Inc. (NASDAQ:MEDP) Receives Average Rating of “Hold” from Brokerages
Shares of Medpace Holdings, Inc. (NASDAQ: MEDP - Get Free Report) have earned a consensus rating of "Hold" from the fifteen ratings firms that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, nine have issued a hold recommendation and five have issued a buy recommendation on
Medpace (MEDP) Rises As Market Takes a Dip: Key Facts
Medpace (MEDP) reached $447.09 at the closing of the latest trading day, reflecting a +2.06% change compared to its last close.
Medpace Holdings, Inc. (MEDP) Q4 2025 Earnings Call Transcript
Medpace Holdings, Inc. (MEDP) Q4 2025 Earnings Call Transcript
Medpace Holdings: Great Quarter, Stale Backlog, Full Valuation
Medpace Holdings delivered strong Q4 and FY 2025 results, beating revenue and EPS expectations, with 32% YoY revenue growth and 27% YoY EPS growth. MEDP's backlog growth remains sluggish, but a healthy book-to-bill ratio and potential sector recovery could accelerate future growth. Valuation is now fair at ~32x P/E, with a DCF suggesting modest 6% upside; disciplined share buybacks continue to support EPS growth.
Medpace (MEDP) Beats Q4 Earnings and Revenue Estimates
Medpace (MEDP) came out with quarterly earnings of $4.67 per share, beating the Zacks Consensus Estimate of $4.18 per share. This compares to earnings of $3.67 per share a year ago.
Medpace (MEDP) Declines More Than Market: Some Information for Investors
In the most recent trading session, Medpace (MEDP) closed at $582.48, indicating a -1.79% shift from the previous trading day.
Why the Market Dipped But Medpace (MEDP) Gained Today
Medpace (MEDP) closed at $616.45 in the latest trading session, marking a +1.32% move from the prior day.
Medpace (MEDP) Stock Dips While Market Gains: Key Facts
Medpace (MEDP) closed the most recent trading day at $600.02, moving 2.13% from the previous trading session.
